Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
Stem Pharm has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in September 2026.
Stem Pharm's investors include National Institutes of Health, Wisconsin Economic Development, Small Business Innovation Research, National Institute on Aging, SBIR Advance.
Stem Pharm is headquartered in Madison, United States.
Stem Pharm's synthetic biomaterials support the optimization of cell expansion.
Stem Pharm is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Stem Pharm — Funding & Investors." VCBacked, September 18, 2026, https://www.vcbacked.co/company/stem-pharm. Accessed October 19, 2026.
VCBacked. (2026). Stem Pharm — Funding & Investors. Retrieved October 19, 2026, from https://www.vcbacked.co/company/stem-pharm
{{cite web |title=Stem Pharm — Funding & Investors |url=https://www.vcbacked.co/company/stem-pharm |website=VCBacked |access-date=October 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated